PlainRecalls
FDA Drug Low Class III Ongoing

MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc., Boulder, CO 80301. NDC: 70255-010-02

Reported: April 19, 2023 Initiated: March 8, 2023 #D-0532-2023

Product Description

MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc., Boulder, CO 80301. NDC: 70255-010-02

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.

Details

Recalling Firm
Pfizer Inc.
Units Affected
1,926 Bottles
Distribution
Nationwide in the USA
Location
New York, NY

Frequently Asked Questions

What product was recalled?
MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer Inc., Boulder, CO 80301. NDC: 70255-010-02. Recalled by Pfizer Inc.. Units affected: 1,926 Bottles.
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 19, 2023. Severity: Low. Recall number: D-0532-2023.